Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/3/2026
- Wall Street rallies, Dow closes at record on Iran talks optimism
- Fed's Williams says rate hikes possible if inflation persists
- Citi says buy these 3 chip stocks on pullback
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Deutsche Bank raises S&P 500 earnings estimates on the back of the solid Q2 beats
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
BioMarin Pharma (BMRN) Enters $600M Revolving Credit Facility
September 4, 2024 12:57 PM EDTOn August 28, 2024, BioMarin Pharma (NASDAQ: BMRN), entered into a Credit Agreement (the Credit Agreement) with Citibank, N.A., as Administrative Agent (Citibank or the Administrative Agent), and the Lenders party thereto (the Lenders).
The Credit Agreement provides for up to $600 million in revolving loans (the Revolving Credit Facility), none of which was drawn at closing. Subject to the satisfaction of certain conditions precedent, the Company will be entitled to draw funds at its discretion until the Revolving Credit Facility matures on August 28, 2029 (the Maturity Date), at which time all outstanding loans shall become due and payable and all... More
